FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Non-Opioid Analgesic Development Guidance

[ Price : $8.95]

FDA publishes a draft guidance to assist in developing non-opioid analgesics to treat chronic pain.

Apollo TMS Cleared for Depressed Adolescents

[ Price : $8.95]

FDA clears a new indication for neurocare groups Apollo TMS therapy device to treat adolescents with major depressive disorder.

FDA Approves J&Js New Bladder Cancer Therapy

[ Price : $8.95]

FDA approves a Johnson & Johnson NDA for Inlexzo (gemcitabine intravesical system) for adults with non-muscle invasive bladder can...

Greenwich Gets Fast Track for Breast Cancer Therapy

[ Price : $8.95]

FDA grants Greenwich LifeSciences fast track status for GLSI-100 for preventing breast cancer recurrences.

FDA Orders Crackdown on Misleading Prescription Drug Ads

[ Price : $8.95]

In a new crackdown on drug advertising, FDA orders pharmaceutical companies to remove any noncompliant ads and bring all promotion...

FDA Digital Health Leader Leaves for Mayo Clinic

[ Price : $8.95]

Former FDA Digital Health Center of Excellence acting director Sonja Fulmer leaves the agency to accept a position at Mayo Clinic ...

Expanded Approval for AZs Koselugo

[ Price : $8.95]

FDA approves an expanded indication to include pediatric patients aged one and older for AstraZenecas Koselugo to treat some cases...

CGMP API Deviations at Hikal Limited

[ Price : $8.95]

FDA warns Jigani, Karnataka, India-based Hikal Limited about CGMP deviations in its production of active pharmaceutical ingredient...

Issues in 3 Trials Conducted by Detroit Doctor

[ Price : $8.95]

FDA warns Detroit, MI-based medical oncologist Shirish Gadgeel about bioresearch monitoring violations in his conduct of three cli...

Former CBER Therapeutics Deputy Anatol Joins Lilly

[ Price : $8.95]

Eli Lilly hires former CBER Office of Therapeutic Products (OTP) deputy director Rachael Anatol, who was removed from her agency p...